David A. Siegel Isoray, Inc. Transaction History

Two Sigma Advisers, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	N/A	-9,300 Reduced 28.7%	23,100 $15,000
Q4 2023 Feb 14, 2024	SELL	N/A	-200 Reduced 0.61%	32,400 $22,000
Q3 2023 Nov 14, 2023	SELL	N/A	-3,600 Reduced 9.94%	32,600 $22,000
Q2 2023 Aug 14, 2023	SELL	$0.0 - $0.69 $0 - $3,863	-5,600 Reduced 13.4%	36,200 $24,000
Q1 2023 May 15, 2023	SELL	$0.0 - $0.67 $0 - $1,809	-2,700 Reduced 6.07%	41,800 $26,000
Q3 2022 Nov 14, 2022	SELL	$0.22 - $0.43 $2,178 - $4,257	-9,900 Reduced 18.2%	44,500 $10,000
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.37 $2,964 - $4,218	-11,400 Reduced 17.33%	54,400 $17,000
Q1 2022 May 16, 2022	BUY	$0.31 - $0.41 $8,122 - $10,742	26,200 Added 66.16%	65,800 $24,000
Q4 2021 Feb 14, 2022	BUY	$0.38 - $0.68 $15,048 - $26,928	39,600 New	39,600 $15,000
Q2 2021 Aug 16, 2021	SELL	$0.75 - $1.15 $38,775 - $59,454	-51,700 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.53 - $2.47 $27,401 - $127,699	51,700 New	51,700 $56,000

145K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.